"Cowen’s Eric Schmidt just wrote a “quick take” report estimating that NVS’ 4Q10 end-user Lovenox sales were $200-225M, which is consistent with my run-rate estimate in #msg-59286675. FWIW"
Dew, are you saying NVS reported $170 million while MNTA will report $200 - $225 million fo Q4?